Key stats
About 21SHARES INJECTIVE STAKING ETP
Home page
Inception date
Jul 9, 2024
Structure
Swiss CISA
Replication method
Synthetic
Dividend treatment
Capitalizes
Primary advisor
21Shares AG
ISIN
CH1360612134
AINJ is designed to provide exposure to the performance of Injective (INJ) (the underlying asset(s)). Price data (in USD) from CCData (ccdata.io/) is used to calculate the price of the reference asset.
Classification
Symbol
Geography
Global
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Cash
Bonds, Cash & Other100.00%
Cash100.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
AINJ-EUR assets under management is 2.04 M EUR. It's fallen 0.51% over the last month.
AINJ-EUR fund flows account for 116.57 K EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, AINJ-EUR doesn't pay dividends to its holders.
AINJ-EUR shares are issued by 21Shares AG under the brand 21Shares. The ETF was launched on Jul 9, 2024, and its management style is Passive.
AINJ-EUR expense ratio is 2.50% meaning you'd have to pay 2.50% of your investment to help manage the fund.
AINJ-EUR invests in cash.
AINJ-EUR trades at a premium (1.53%) meaning the ETF is trading at a higher price than the calculated NAV.